BROMHEXIN Hermes Arzneimittel 12 mg/ml drops, 100 ml

Instructions for use for BROMHEXIN Hermes Arzneimittel 12 mg/ml drops, 100 ml

Detailed instructions for BROMHEXIN Hermes Arzneimittel 12 mg/ml drops, 100 ml

Field of use

For expectorant treatment for acute and chronic diseases of the bronchi and lungs with a tough mucus.

Active ingredients / ingredients / ingredients

12 mg bromhexine hydrochloride
10.94 mg bromhexin
Glycerol auxiliary substance (+)
Propylen glycol auxiliary substance (+)
Anis oil auxiliary material (+)
Bitter fennel oil auxiliary material (+)
Levomenthol auxiliary substance (+)
Peppermint oil auxiliary material (+)

Contradictions

The drug must not be taken- if you are hypersensitive to bromhexin hydrochloride or one of the other components- if you have a stomach or duodenum ulcer ulcer, since the medicine can influence the mucous membrane barrier of the stomach and intestine- of infants and toddlers under 2 years (danger of larynx)- from patients with bronchial asthma or other respiratory diseases that are associated with a pronounced hypersensitivity of the airways. The inhalation of the drug can lead to shortness of breath or trigger a asthma attack.

dosage

Unless otherwise prescribed by the doctor, the usual dose is:-Adults and adolescents over 14 years: 3 times a day 16-33 drops (corresponding to 24-48 mg bromhexin hydrochloride)-children and adolescents between 6 and 14 years as well as patients under 50 KG body weight: 3 times a day 16 drops (corresponding to 24 mg bromhexin hydrochloride)-children from 2 to 6 years: 3 times a day 8 drops (corresponding to 12 mg bromhexin hydrochloride) every day)

If the kidney function or severe liver disease is restricted, the dosage should be reduced accordingly. Please ask your doctor. Notice: The supply of enough liquid can be useful. If the clinical picture worsens or no improvement occurs after 4-5 days, you should see a doctor. Please speak to your doctor or pharmacist if you have the impression that the effect is too strong or too weak. If there are severe signs of illness, circulatory monitoring and, if necessary, treatment -oriented treatment may be necessary. If a child has swallowed significant amounts of the drug, contact the next accessible doctor. Once you have forgotten to take the medicine or have taken too little, please set the medicine next time, as described in the dosage instructions, please continue to break the treatment with the medicine without consulting your doctor away. This could deteriorate their illness. If you have any further questions about the application of the drug, ask your doctor or pharmacist.     

Taking

The drops must be taken.
The expectorant effect of the drug can be supported by fluid intake.

Patient information

It is very rare about the occurrence of severe skin reactions such as Stevens-Johnson syndrome and Lyell syndrome has been reported in a temporal connection with the use of bromhexin. When the skin and mucous membrane changes come back, medical advice should be obtained immediately and the application of the medicine should be ended. They may only take the medicine after consultation with their doctor:- In some rare diseases of the bronchi, which are accompanied by excessive secretion collection (e.g. malignant zilien syndrome ), if the medicine is only used under medical control due to a possible secretion of a secretion. If the kidney function is severely disturbed, the dismantling products formed in the liver must be included in the liver. There are no special features to be observed. Store drug out of reach of children.     

Pregnancy

Ask your doctor or pharmacist for advice before taking/using all medicinal products. With an application of this medicine in pregnancy in humans, there is no experience so far, so the medicine during pregnancy may only be subject to strict use-risk assessment by the doctor to be taken. Bromhexin merges into breast milk. Since the effects on the infant are insufficiently examined, the medicine must not be taken during breastfeeding.

Hints

Miscellaneous

- The expression-resolution effect of the drug is supported by fluid intake. - In the event of serious liver disease, a reduction in the excretion of the active ingredient can be expected. In the case of severely reduced kidney function, an extension of the elimination time of the dismantling products of the active ingredient is not excluded. In the event of severe liver or kidney dysfunction, the amount should therefore be reduced accordingly. $ Therapy monitoring/control measures: $, especially with long -term application, occasional monitoring of the liver function is advisable.

Manufacturer:  HERMES Arzneimittel GmbH, Georg-Kalb-Straße 5-8, 82049 Grosshesselohe